Gadolinium Levels: The test determines the amount of gadolinium in serum, helping to evaluate exposure after its use as a contrast agent in magnetic resonance imaging (MRI). Effects of Exposure: The test can reveal if there are abnormally high levels of gadolinium, which may indicate potential health risks, especially in patients with kidney problems. Monitoring Kidney Function: The test is important for assessing gadolinium’s impact on kidney function, as elevated levels may cause kidney issues or lead to a rare but serious condition called "nephrogenic systemic fibrosis." Determining Appropriate Doses: The test helps verify whether the gadolinium dose used in imaging is safe, aiding in optimizing the use of contrast agents in medical examinations.

Patients who underwent MRI scans: The test is recommended for individuals who received gadolinium injections as a contrast agent in imaging procedures. Patients with kidney disease: Recommended for individuals with a history of kidney function issues, as they are more susceptible to gadolinium effects. Patients showing abnormal symptoms after imaging: Such as pain at the injection site, swelling, or any unusual symptoms that may indicate potential side effects of gadolinium. Patients with chronic diseases: Such as diabetes or high blood pressure, which may affect kidney function and increase the risk of toxicity. Individuals who received high doses of gadolinium: Including patients who underwent repeated imaging requiring contrast agents. Individuals taking medications that may affect kidney function: Such as NSAIDs or diuretics, which increase the likelihood of negative gadolinium effects.

Swelling or pain at the injection site: Unusual inflammation or pain at the site of gadolinium injection may indicate a reaction or problem. Kidney-related symptoms: Such as changes in urine output, difficulty urinating, or swelling in the legs or feet, which may indicate gadolinium effects on kidney function. Nausea or vomiting: Experiencing nausea or vomiting after MRI may warrant the test. Dizziness or loss of consciousness: Any sudden dizziness or fainting after injection may require evaluating gadolinium levels. Skin rash or allergic reactions: Any rash or signs of allergic reaction after gadolinium use may indicate the need for testing. Changes in mental state: Such as confusion or sudden mood changes, which may suggest potential negative effects. Unexplained symptoms: Any unusual symptoms after MRI, like extreme fatigue or insomnia, may signal the need for testing.

What is the purpose of this test? The test aims to measure gadolinium levels in the body after its use as a contrast agent in MRI to ensure patient safety. When is this test recommended? It is recommended when abnormal symptoms appear after gadolinium use, or for patients with kidney problems. How is the test performed? A blood sample is drawn from the arm and sent to the laboratory to analyze gadolinium levels. Does the test require fasting? Usually, fasting is not required, but it is always best to follow the instructions provided by the doctor or laboratory. How are the test results interpreted? Results indicate gadolinium levels in the blood and should be reviewed with a doctor to determine if they are within the normal range or if treatment adjustments are needed. Are there any risks associated with the test? The test is generally safe, but minor risks may include pain or bruising at the blood draw site. Does every patient need this test after MRI? No, not all patients need this test; it is performed only for individuals showing symptoms requiring monitoring or those with a history of kidney problems. What happens if the results are abnormal? This may require adjusting the treatment plan or monitoring other conditions to ensure patient safety. Can other factors affect the test results? Yes, certain medications or other health conditions can affect gadolinium levels, so it is important to inform the doctor of all medications being taken.

Normal gadolinium levels in blood: Gadolinium levels are usually undetectable or range from 0 to 5 ng/mL in untreated individuals or those not exposed to high doses of gadolinium. Dose-related levels: After gadolinium use as a contrast agent, blood levels may rise and should be monitored to avoid negative effects. Post-injection levels can range from 10 to 300 ng/mL or more, depending on the administered dose and the patient’s health condition. Abnormal levels: Significantly elevated levels may indicate potential adverse effects on kidney function or other risks, requiring evaluation and treatment.

Gadolinium Level Test Price | Lahalak Platform

Accurately measure Gadolinium levels used in MRI scans to ensure kidney safety and confirm the body has safely eliminated the contrast agent after imaging.

Prices starts from: 158.4 SAR

Scientific name: Gadolinium Level Test

Gadolinium analysis is a test used to measure gadolinium levels in the body, an element commonly used as a contrast agent in magnetic resonance imaging (MRI). Gadolinium-based contrast agents are administered to improve the clarity of medical images, helping doctors diagnose a variety of medical conditions, including tumors, vascular diseases, and...

Gadolinium Level Test - Check Your Gadolinium Levels

Service type Laboratory test (Blood)

Duration 10-15 minutes

Fasting Fasting is not required

Prices Starting from 158.4 SAR

Included Services

Gadolinium Test
The optimal health guidance based on the result.
Personal support services from Lahalak

Medical Service Information

Purpose Test

Gadolinium Levels: The test determines the amount of gadolinium in serum, helping to evaluate exposure after its use as a contrast agent in magnetic resonance imaging (MRI).
Effects of Exposure: The test can reveal if there are abnormally high levels of gadolinium, which may indicate potential health risks, especially in patients with kidney problems.
Monitoring Kidney Function: The test is important for assessing gadolinium’s impact on kidney function, as elevated levels may cause kidney issues or lead to a rare but serious condition called "nephrogenic systemic fibrosis."
Determining Appropriate Doses: The test helps verify whether the gadolinium dose used in imaging is safe, aiding in optimizing the use of contrast agents in medical examinations.

Recommended groups

Patients who underwent MRI scans: The test is recommended for individuals who received gadolinium injections as a contrast agent in imaging procedures.
Patients with kidney disease: Recommended for individuals with a history of kidney function issues, as they are more susceptible to gadolinium effects.
Patients showing abnormal symptoms after imaging: Such as pain at the injection site, swelling, or any unusual symptoms that may indicate potential side effects of gadolinium.
Patients with chronic diseases: Such as diabetes or high blood pressure, which may affect kidney function and increase the risk of toxicity.
Individuals who received high doses of gadolinium: Including patients who underwent repeated imaging requiring contrast agents.
Individuals taking medications that may affect kidney function: Such as NSAIDs or diuretics, which increase the likelihood of negative gadolinium effects.

Symptoms indicative

Swelling or pain at the injection site: Unusual inflammation or pain at the site of gadolinium injection may indicate a reaction or problem.
Kidney-related symptoms: Such as changes in urine output, difficulty urinating, or swelling in the legs or feet, which may indicate gadolinium effects on kidney function.
Nausea or vomiting: Experiencing nausea or vomiting after MRI may warrant the test.
Dizziness or loss of consciousness: Any sudden dizziness or fainting after injection may require evaluating gadolinium levels.
Skin rash or allergic reactions: Any rash or signs of allergic reaction after gadolinium use may indicate the need for testing.
Changes in mental state: Such as confusion or sudden mood changes, which may suggest potential negative effects.

FAQs

What is the purpose of this test? The test aims to measure gadolinium levels in the body after its use as a contrast agent in MRI to ensure patient safety.
When is this test recommended? It is recommended when abnormal symptoms appear after gadolinium use, or for patients with kidney problems.
How is the test performed? A blood sample is drawn from the arm and sent to the laboratory to analyze gadolinium levels.
Does the test require fasting? Usually, fasting is not required, but it is always best to follow the instructions provided by the doctor or laboratory.
How are the test results interpreted? Results indicate gadolinium levels in the blood and should be reviewed with a doctor to determine if they are within the normal range or if treatment adjustments are needed.
Are there any risks associated with the test? The test is generally safe, but minor risks may include pain or bruising at the blood draw site.

Normal Levels

Normal gadolinium levels in blood: Gadolinium levels are usually undetectable or range from 0 to 5 ng/mL in untreated individuals or those not exposed to high doses of gadolinium.
Dose-related levels: After gadolinium use as a contrast agent, blood levels may rise and should be monitored to avoid negative effects. Post-injection levels can range from 10 to 300 ng/mL or more, depending on the administered dose and the patient’s health condition.
Abnormal levels: Significantly elevated levels may indicate potential adverse effects on kidney function or other risks, requiring evaluation and treatment.